Genomic epidemiology supports multiple introductions and cryptic transmission of Zika virus in Colombia.
Colombia
Genomic epidemiology
Phylogeography
Virus evolution
Zika virus
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
12 Nov 2019
12 Nov 2019
Historique:
received:
09
05
2019
accepted:
16
10
2019
entrez:
14
11
2019
pubmed:
14
11
2019
medline:
18
12
2019
Statut:
epublish
Résumé
Colombia was the second most affected country during the American Zika virus (ZIKV) epidemic, with over 109,000 reported cases. Despite the scale of the outbreak, limited genomic sequence data were available from Colombia. We sought to sequence additional samples and use genomic epidemiology to describe ZIKV dynamics in Colombia. We sequenced ZIKV genomes directly from clinical diagnostic specimens and infected Aedes aegypti samples selected to cover the temporal and geographic breadth of the Colombian outbreak. We performed phylogeographic analysis of these genomes, along with other publicly-available ZIKV genomes from the Americas, to estimate the frequency and timing of ZIKV introductions to Colombia. We attempted PCR amplification on 184 samples; 19 samples amplified sufficiently to perform sequencing. Of these, 8 samples yielded sequences with at least 50% coverage. Our phylogeographic reconstruction indicates two separate introductions of ZIKV to Colombia, one of which was previously unrecognized. We find that ZIKV was first introduced to Colombia in February 2015 (95%CI: Jan 2015 - Apr 2015), corresponding to 5 to 8 months of cryptic ZIKV transmission prior to confirmation in September 2015. Despite the presence of multiple introductions, we find that the majority of Colombian ZIKV diversity descends from a single introduction. We find evidence for movement of ZIKV from Colombia into bordering countries, including Peru, Ecuador, Panama, and Venezuela. Similarly to genomic epidemiological studies of ZIKV dynamics in other countries, we find that ZIKV circulated cryptically in Colombia. More accurately dating when ZIKV was circulating refines our definition of the population at risk. Additionally, our finding that the majority of ZIKV transmission within Colombia was attributable to transmission between individuals, rather than repeated travel-related importations, indicates that improved detection and control might have succeeded in limiting the scale of the outbreak within Colombia.
Sections du résumé
BACKGROUND
BACKGROUND
Colombia was the second most affected country during the American Zika virus (ZIKV) epidemic, with over 109,000 reported cases. Despite the scale of the outbreak, limited genomic sequence data were available from Colombia. We sought to sequence additional samples and use genomic epidemiology to describe ZIKV dynamics in Colombia.
METHODS
METHODS
We sequenced ZIKV genomes directly from clinical diagnostic specimens and infected Aedes aegypti samples selected to cover the temporal and geographic breadth of the Colombian outbreak. We performed phylogeographic analysis of these genomes, along with other publicly-available ZIKV genomes from the Americas, to estimate the frequency and timing of ZIKV introductions to Colombia.
RESULTS
RESULTS
We attempted PCR amplification on 184 samples; 19 samples amplified sufficiently to perform sequencing. Of these, 8 samples yielded sequences with at least 50% coverage. Our phylogeographic reconstruction indicates two separate introductions of ZIKV to Colombia, one of which was previously unrecognized. We find that ZIKV was first introduced to Colombia in February 2015 (95%CI: Jan 2015 - Apr 2015), corresponding to 5 to 8 months of cryptic ZIKV transmission prior to confirmation in September 2015. Despite the presence of multiple introductions, we find that the majority of Colombian ZIKV diversity descends from a single introduction. We find evidence for movement of ZIKV from Colombia into bordering countries, including Peru, Ecuador, Panama, and Venezuela.
CONCLUSIONS
CONCLUSIONS
Similarly to genomic epidemiological studies of ZIKV dynamics in other countries, we find that ZIKV circulated cryptically in Colombia. More accurately dating when ZIKV was circulating refines our definition of the population at risk. Additionally, our finding that the majority of ZIKV transmission within Colombia was attributable to transmission between individuals, rather than repeated travel-related importations, indicates that improved detection and control might have succeeded in limiting the scale of the outbreak within Colombia.
Identifiants
pubmed: 31718580
doi: 10.1186/s12879-019-4566-2
pii: 10.1186/s12879-019-4566-2
pmc: PMC6852897
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
963Subventions
Organisme : Gobernacion de Cordoba
ID : 754/2013
Organisme : NIH HHS
ID : U54 GM111274
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM119774
Pays : United States
Organisme : NIH HHS
ID : R35 GM119774-01
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM111274
Pays : United States
Organisme : National Science Foundation
ID : DGE-1256082
Organisme : NIH HHS
ID : S10 OD020069
Pays : United States
Références
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9294-9299
pubmed: 30150394
Lancet Infect Dis. 2016 Jun;16(6):653-660
pubmed: 26897108
Nucleic Acids Res. 2012 Jan;40(Database issue):D593-8
pubmed: 22006842
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Nat Commun. 2018 Apr 11;9(1):1391
pubmed: 29643334
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
N Engl J Med. 2016 Jun 15;:null
pubmed: 27305043
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
PLoS Negl Trop Dis. 2016 Apr 25;10(4):e0004687
pubmed: 27111294
Cell Host Microbe. 2018 Jun 13;23(6):855-864.e7
pubmed: 29805095
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Science. 2016 Apr 15;352(6283):345-349
pubmed: 27013429
MBio. 2016 Oct 11;7(5):
pubmed: 27729507
Nature. 2017 Jun 15;546(7658):411-415
pubmed: 28538734
Emerg Infect Dis. 2016 May;22(5):933-5
pubmed: 27088323
N Engl J Med. 2016 Oct 20;375(16):1513-1523
pubmed: 27705091
Euro Surveill. 2016 Jul 14;21(28):
pubmed: 27452806
Nature. 2017 Jun 15;546(7658):406-410
pubmed: 28538727
Virol J. 2013 Oct 22;10:311
pubmed: 24148652
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
J Infect Dis. 2016 Nov 1;214(9):1349-1356
pubmed: 27436433
JAMA Pediatr. 2017 Mar 1;171(3):288-295
pubmed: 27812690
Emerg Infect Dis. 2017 Apr;23(4):669-672
pubmed: 28084987
Medicine (Baltimore). 2016 Mar;95(12):e3201
pubmed: 27015222
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Asian Pac J Trop Med. 2016 May;9(5):445-52
pubmed: 27261852
MBio. 2017 Nov 14;8(6):
pubmed: 29138300
MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1409-1413
pubmed: 27977645
Science. 2016 Aug 12;353(6300):aaf8160
pubmed: 27417495
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Nature. 2017 Jun 15;546(7658):401-405
pubmed: 28538723
Emerg Infect Dis. 2016 Oct;22(10):1788-92
pubmed: 27448188
Lancet. 2016 Jan 16;387(10015):227-8
pubmed: 26775124